Comparative Evaluation of Anti-Inflammatory Properties of Chitosan Extracted from the Scales of <i>Labeo rohita</i> and <i>Anabas testudineus</i>: An <i>In Vitro</i> Study
Inflammation is a natural physiological process involved in many acute and chronic diseases and there is a great need for developing new safer, natural anti-inflammatory agents․ Chitosan is a biocompatible polysaccharide, produced by chitin deacetylation, and has been extensively studied due to its several biological activities, including anti-inflammatory properties․ The in vitro anti-inflammatory effect of commercial chitosan was compared with that of fish chitosan sourced from two species: Labeo rohita , and Anabas testudineus ․ The modes of action of the anti-inflammatory activity of the chitosan were determined by measuring its ability to inhibit proteinase and hyaluronidase, as well as its Lipoxygenase (LOX) inhibition activity (assessed by LOX reaction with a synthetic substrate) and its membrane stabilising activity (determined by the polysaccharide’s ability to reduce heat-induced and hypotonicity-induced hemolysis)․ In this study, anti-inflammatory drugs such as diclofenac sodium, aspirin and indomethacin were used as positive control․ A concentration-dependent inhibition of inflammation-related processes was found in all chitosan samples․ For commercial chitosan, greater inhibition was achieved at a lower concentration, whereas fish chitosan had the same or greater inhibition at a higher concentration․ The in vitro anti-inflammatory potential of the fish-based extracts was attributed to L. rohita and A. testudineus chitosan based on enzyme inhibition and membrane stabilisation measurements․ The proteinase inhibitory activity increased dose-dependently, with commercial chitosan showing the highest inhibition among the fish-derived chitosans (59.75% at 500 μg/mL), followed by L. rohita (40.25%) and A. testudineus,/i> (32.94%), as compare to positive control. The anti-inflammatory activity of chitosan is likely caused by a combination of the inhibition of inflammation-related enzymes and the stabilisation of cellular membranes a